Viewing Study NCT03840902


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-03-01 @ 3:01 PM
Study NCT ID: NCT03840902
Status: TERMINATED
Last Update Posted: 2024-01-16
First Post: 2019-02-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Sponsor: EMD Serono Research & Development Institute, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MS200647_0005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View